• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质序列中的保守差异决定了埃博拉病毒对人类的致病性。

Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses.

作者信息

Pappalardo Morena, Juliá Miguel, Howard Mark J, Rossman Jeremy S, Michaelis Martin, Wass Mark N

机构信息

Centre for Molecular Processing and School of Biosciences, University of Kent, Canterbury, Kent CT2 7NJ, UK.

出版信息

Sci Rep. 2016 Mar 24;6:23743. doi: 10.1038/srep23743.

DOI:10.1038/srep23743
PMID:27009368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4806318/
Abstract

Reston viruses are the only Ebolaviruses that are not pathogenic in humans. We analyzed 196 Ebolavirus genomes and identified specificity determining positions (SDPs) in all nine Ebolavirus proteins that distinguish Reston viruses from the four human pathogenic Ebolaviruses. A subset of these SDPs will explain the differences in human pathogenicity between Reston and the other four ebolavirus species. Structural analysis was performed to identify those SDPs that are likely to have a functional effect. This analysis revealed novel functional insights in particular for Ebolavirus proteins VP40 and VP24. The VP40 SDP P85T interferes with VP40 function by altering octamer formation. The VP40 SDP Q245P affects the structure and hydrophobic core of the protein and consequently protein function. Three VP24 SDPs (T131S, M136L, Q139R) are likely to impair VP24 binding to human karyopherin alpha5 (KPNA5) and therefore inhibition of interferon signaling. Since VP24 is critical for Ebolavirus adaptation to novel hosts, and only a few SDPs distinguish Reston virus VP24 from VP24 of other Ebolaviruses, human pathogenic Reston viruses may emerge. This is of concern since Reston viruses circulate in domestic pigs and can infect humans, possibly via airborne transmission.

摘要

雷斯顿病毒是唯一对人类无致病性的埃博拉病毒。我们分析了196个埃博拉病毒基因组,并在所有9种埃博拉病毒蛋白中确定了特异性决定位点(SDPs),这些位点可将雷斯顿病毒与四种人类致病性埃博拉病毒区分开来。这些SDPs的一个子集将解释雷斯顿病毒与其他四种埃博拉病毒在人类致病性上的差异。进行了结构分析以确定那些可能具有功能影响的SDPs。该分析揭示了特别是对于埃博拉病毒蛋白VP40和VP24的新功能见解。VP40的SDP P85T通过改变八聚体形成来干扰VP40功能。VP40的SDP Q245P影响该蛋白的结构和疏水核心,从而影响蛋白功能。三个VP24的SDPs(T131S、M136L、Q139R)可能会损害VP24与人核转运蛋白α5(KPNA5)的结合,进而抑制干扰素信号传导。由于VP24对埃博拉病毒适应新宿主至关重要,并且只有少数SDPs将雷斯顿病毒的VP24与其他埃博拉病毒的VP24区分开来,因此可能会出现具有人类致病性的雷斯顿病毒。这令人担忧,因为雷斯顿病毒在家猪中传播,并且可能通过空气传播感染人类。

相似文献

1
Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses.蛋白质序列中的保守差异决定了埃博拉病毒对人类的致病性。
Sci Rep. 2016 Mar 24;6:23743. doi: 10.1038/srep23743.
2
Investigating Ebola virus pathogenicity using molecular dynamics.利用分子动力学研究埃博拉病毒致病性
BMC Genomics. 2017 Aug 11;18(Suppl 5):566. doi: 10.1186/s12864-017-3912-2.
3
VP24-Karyopherin Alpha Binding Affinities Differ between Ebolavirus Species, Influencing Interferon Inhibition and VP24 Stability.埃博拉病毒不同物种之间的VP24-核转运蛋白α结合亲和力存在差异,影响干扰素抑制作用和VP24稳定性。
J Virol. 2017 Jan 31;91(4). doi: 10.1128/JVI.01715-16. Print 2017 Feb 15.
4
Is the Bombali virus pathogenic in humans?巴姆巴利病毒是否对人类具有致病性?
Bioinformatics. 2019 Oct 1;35(19):3553-3558. doi: 10.1093/bioinformatics/btz267.
5
The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold.埃博拉病毒干扰素拮抗剂 VP24 直接结合 STAT1 并具有新颖的金字塔折叠结构。
PLoS Pathog. 2012 Feb;8(2):e1002550. doi: 10.1371/journal.ppat.1002550. Epub 2012 Feb 23.
6
Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.埃博拉病毒VP24蛋白抑制NPI-1亚家族核转运蛋白α蛋白与活化的信号转导和转录激活因子1(STAT1)之间的相互作用。
J Virol. 2007 Dec;81(24):13469-77. doi: 10.1128/JVI.01097-07. Epub 2007 Oct 10.
7
Changes associated with Ebola virus adaptation to novel species.埃博拉病毒适应新物种相关的变化。
Bioinformatics. 2017 Jul 1;33(13):1911-1915. doi: 10.1093/bioinformatics/btx065.
8
Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24.埃博拉病毒属种特异性干扰素拮抗作用由 VP24 介导。
Viruses. 2023 Apr 28;15(5):1075. doi: 10.3390/v15051075.
9
An all-atom molecular dynamics study of the anti-interferon signaling of Ebola virus: interaction mechanisms of EBOV VP24 binding to Karyopherin alpha5.埃博拉病毒抗干扰素信号传导的全原子分子动力学研究:埃博拉病毒糖蛋白VP24与核转运蛋白α5的相互作用机制
Mol Biosyst. 2017 May 2;13(5):1031-1045. doi: 10.1039/c7mb00136c.
10
Serological evidence of exposure to ebolaviruses in domestic pigs from Guinea.来自几内亚的家猪中埃博拉病毒感染的血清学证据。
Transbound Emerg Dis. 2020 Mar;67(2):724-732. doi: 10.1111/tbed.13391. Epub 2019 Nov 2.

引用本文的文献

1
Influence of glycosylation on the immunogenicity and antigenicity of viral immunogens.糖基化对病毒免疫原的免疫原性和抗原性的影响。
Biotechnol Adv. 2024 Jan-Feb;70:108283. doi: 10.1016/j.biotechadv.2023.108283. Epub 2023 Nov 14.
2
Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24.埃博拉病毒属种特异性干扰素拮抗作用由 VP24 介导。
Viruses. 2023 Apr 28;15(5):1075. doi: 10.3390/v15051075.
3
Activation of Toll-like receptor 4 by Ebola virus-shed glycoprotein is direct and requires the internal fusion loop but not glycosylation.

本文引用的文献

1
Shedding of Ebola Virus in an Asymptomatic Pregnant Woman.一名无症状孕妇体内埃博拉病毒的脱落
N Engl J Med. 2015 Jun 18;372(25):2467-9. doi: 10.1056/NEJMc1503275.
2
Niemann-pick C1 is essential for ebolavirus replication and pathogenesis in vivo.尼曼-皮克病C1蛋白对于埃博拉病毒在体内的复制和致病机制至关重要。
mBio. 2015 May 26;6(3):e00565-15. doi: 10.1128/mBio.00565-15.
3
Systematic Genome-wide Screening and Prediction of microRNAs in EBOV During the 2014 Ebolavirus Outbreak.2014年埃博拉病毒爆发期间埃博拉病毒中微小RNA的全基因组系统筛选与预测
埃博拉病毒脱落糖蛋白通过 Toll 样受体 4 的激活是直接的,需要内部融合环而不是糖基化。
Cell Rep. 2022 Oct 25;41(4):111562. doi: 10.1016/j.celrep.2022.111562.
4
Zoonotic and reverse zoonotic transmission of viruses between humans and pigs.病毒在人类和猪之间的人畜共患和反向人畜共患传播。
APMIS. 2021 Dec;129(12):675-693. doi: 10.1111/apm.13178. Epub 2021 Oct 18.
5
Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity.埃博拉病毒的物种和变体特异性的致病性和毒力。
Virulence. 2021 Dec;12(1):885-901. doi: 10.1080/21505594.2021.1898169.
6
Unraveling the molecular basis of host cell receptor usage in SARS-CoV-2 and other human pathogenic β-CoVs.解析严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其他人类致病性β冠状病毒中宿主细胞受体使用的分子基础。
Comput Struct Biotechnol J. 2021;19:759-766. doi: 10.1016/j.csbj.2021.01.006. Epub 2021 Jan 12.
7
Risk assessment of Ebola Reston virus in humans in the Philippines.菲律宾埃博拉莱斯顿病毒在人类中的风险评估。
Western Pac Surveill Response J. 2019 Jul 5;10(3):1-8. doi: 10.5365/wpsar.2017.3.004. eCollection 2019 Jul-Sep.
8
The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses.邦巴里病毒的发现进一步支持了蝙蝠作为埃博拉病毒宿主的说法。
Nat Microbiol. 2018 Oct;3(10):1084-1089. doi: 10.1038/s41564-018-0227-2. Epub 2018 Aug 27.
9
Development of Locked Nucleic Acid Antisense Oligonucleotides Targeting Ebola Viral Proteins and Host Factor Niemann-Pick C1.靶向埃博拉病毒蛋白和宿主因子尼曼-匹克 C1 的锁核酸反义寡核苷酸的研制。
Nucleic Acid Ther. 2018 Oct;28(5):273-284. doi: 10.1089/nat.2018.0722. Epub 2018 Aug 22.
10
Herd Immunity to Ebolaviruses Is Not a Realistic Target for Current Vaccination Strategies.对埃博拉病毒的群体免疫并不是当前疫苗接种策略的现实目标。
Front Immunol. 2018 May 9;9:1025. doi: 10.3389/fimmu.2018.01025. eCollection 2018.
Sci Rep. 2015 May 26;5:9912. doi: 10.1038/srep09912.
4
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.埃博拉病毒VP35和VP24蛋白对人树突状细胞中全球基因表达的不同时间效应
J Virol. 2015 Aug;89(15):7567-83. doi: 10.1128/JVI.00924-15. Epub 2015 May 13.
5
Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs.可溶性糖蛋白并非豚鼠体内埃博拉病毒致病力所必需。
J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S242-6. doi: 10.1093/infdis/jiv111. Epub 2015 May 9.
6
The Phyre2 web portal for protein modeling, prediction and analysis.用于蛋白质建模、预测和分析的Phyre2网络门户。
Nat Protoc. 2015 Jun;10(6):845-58. doi: 10.1038/nprot.2015.053. Epub 2015 May 7.
7
Analysis of Ebola Virus Entry Into Macrophages.埃博拉病毒进入巨噬细胞的分析
J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S247-57. doi: 10.1093/infdis/jiv140. Epub 2015 Apr 14.
8
An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions.来自埃博拉病毒VP35的一种内在无序肽通过调节核蛋白-RNA相互作用来控制病毒RNA合成。
Cell Rep. 2015 Apr 21;11(3):376-89. doi: 10.1016/j.celrep.2015.03.034. Epub 2015 Apr 9.
9
Infectious Diseases. A reassuring snapshot of Ebola.传染病。埃博拉令人安心的简要情况。
Science. 2015 Mar 27;347(6229):1407. doi: 10.1126/science.347.6229.1407.
10
Virology. Mutation rate and genotype variation of Ebola virus from Mali case sequences.病毒学。来自马里病例序列的埃博拉病毒的突变率和基因型变异
Science. 2015 Apr 3;348(6230):117-9. doi: 10.1126/science.aaa5646. Epub 2015 Mar 26.